CONFLICT / Spike

Protalix Biotherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November

CONFLICT signal, reported in IS, from prnewswire.com, with neutral sentiment. Locations: Israel, Carmiel, Ha Afon, Brazil.

Sourcesprnewswire.com
Event Time3 Nov 2026, 12:15 PM GMT
CountryIS
SentimentNeutral / Tone 0.19

What This Signal Means

This page turns one GDELT event record into a readable WorldEchoNews signal. The signal is categorized as CONFLICT for IS, with neutral sentiment and a tone score of 0.19. 1 distinct reporting source linked to this event, and the system marked it as spike activity because related signals increased in the recent event window.

Tone Reading

The tone score is used as a quick language-intensity indicator. Scores below -5 are treated as negative, scores above 5 are treated as positive, and values between -5 and 5 are treated as neutral. This signal has a moderate neutral reading.

Reporting Sources

These source names were attached to matching GDELT mentions for this event.

prnewswire.com
People: Mike Moyer, Chiesi Farmaceutici
Organizations: Pfizer Inc, Drug Administration, European Medicines Agency, Company Link
Locations: Israel, Carmiel, Ha Afon, Brazil
View original source

Activity in IS (last 24 hours)

317signals recorded
-3.29average tone
92strongly negative

Counted across every source WorldEchoNews processed in the window, not just this story.

Other signals from IS